Literature DB >> 31815693

Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.

Sheina Emrani1, Melissa Lamar2, Catherine C Price3, Victor Wasserman1, Emily Matusz4, Rhoda Au5, Rodney Swenson6, Robert Nagele4, Kenneth M Heilman7, David J Libon1,4.   

Abstract

Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common types of dementia. Although the combination of these disorders, called 'mixed' dementia, is recognized, the prevailing clinical and research perspective continues to consider AD and VaD as independent disorders. A review of recent neuropathological and neuropsychological literature reveals that these two disorders frequently co-occur and so-called 'pure' AD or VaD is comparatively rare. In addition, recent research shows that vascular dysfunction not only potentiates AD pathology, but that pathological changes in AD may subsequently induce vascular disorders. On the basis of these data, we propose that the neurobiological underpinnings underlying AD/VaD dementia and their neuropsychological phenotypes are best understood as existing along a clinical/pathological continuum or spectrum. We further propose that in conjunction with current diagnostic criteria, statistical modeling techniques using neuropsychological test performance should be leveraged to construct a system to classify AD/VaD spectrum dementia in order to test hypotheses regarding how mechanisms related to AD and VaD pathology interact and influence each other.

Entities:  

Keywords:  Alzheimer’s disease; episodic memory; executive control; mixed dementia; vascular dementia

Mesh:

Year:  2020        PMID: 31815693     DOI: 10.3233/JAD-190654

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

Review 1.  Hypertension and cognitive function: a review of life-course factors and disparities.

Authors:  Ileana De Anda-Duran; Sara G Woltz; Caryn N Bell; Lydia A Bazzano
Journal:  Curr Opin Cardiol       Date:  2022-07-01       Impact factor: 2.108

Review 2.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

3.  Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe.

Authors:  Emily P Hyle; Julia H A Foote; Fatma M Shebl; Yiqi Qian; Krishna P Reddy; Shibani S Mukerji; Nattanicha Wattananimitgul; Anand Viswanathan; Lee H Schwamm; Ankur Pandya; Kenneth A Freedberg
Journal:  BMJ Open       Date:  2022-07-06       Impact factor: 3.006

4.  Carotid Intima-Media Thickness and Midlife Cognitive Function: Impact of Race and Social Disparities in the Bogalusa Heart Study.

Authors:  Ileana De Anda-Duran; Camilo Fernandez Alonso; David J Libon; Owen T Carmichael; Vijaya B Kolachalama; Shakira F Suglia; Rhoda Au; Lydia A Bazzano
Journal:  Neurology       Date:  2022-02-28       Impact factor: 11.800

5.  Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.

Authors:  Anis Davoudi; Catherine Dion; Shawna Amini; Patrick J Tighe; Catherine C Price; David J Libon; Parisa Rashidi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.

Authors:  Lisa V Graves; Emily C Edmonds; Kelsey R Thomas; Alexandra J Weigand; Shanna Cooper; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 7.  microRNA-Based Biomarkers in Alzheimer's Disease (AD).

Authors:  Yuhai Zhao; Vivian Jaber; Peter N Alexandrov; Andrea Vergallo; Simone Lista; Harald Hampel; Walter J Lukiw
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

Review 8.  Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Vincenzo Di Lazzaro; Giovanni Di Pino
Journal:  Neural Plast       Date:  2020-10-27       Impact factor: 3.599

Review 9.  Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System.

Authors:  Patrizia Hrelia; Giulia Sita; Marina Ziche; Emma Ristori; Angela Marino; Marika Cordaro; Raffaella Molteni; Vittoria Spero; Marco Malaguti; Fabiana Morroni; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2020-08-01       Impact factor: 6.543

Review 10.  APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review.

Authors:  Sheina Emrani; Hirra A Arain; Cassandra DeMarshall; Tal Nuriel
Journal:  Alzheimers Res Ther       Date:  2020-11-04       Impact factor: 8.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.